Lithium Attenuates Brain Injury and Inflammation in Neonatal Rats with Germinal Matrix Hemorrhage

Area of Science:

• Neuroscience
• Neonatal Research
• Pharmacology

Background:

• Germinal matrix hemorrhage (GMH) is a primary cause of mortality and long-term neurodevelopmental deficits in extremely preterm infants.
• Effective therapeutic strategies to mitigate GMH-induced brain injury are critically needed.

Purpose of the Study:

• To investigate the neuroprotective potential of lithium in a neonatal rat model of germinal matrix hemorrhage (GMH).
• To evaluate lithium's effects on brain injury, white matter integrity, inflammation, and neurobehavioral outcomes.

Main Methods:

• GMH was induced in P5 Sprague-Dawley rats using collagenase injections.
• Lithium chloride (LiCl) was administered intraperitoneally post-injury.
• Brain injury, white matter integrity, inflammation, and neurobehavioral outcomes were assessed via MRI, histology, behavioral tests, and molecular analyses.

Main Results:

• Lithium treatment significantly reduced lesion volume by 37% and improved hippocampal white matter integrity.
• Lithium administration alleviated anxiety-like behaviors and enhanced neural stem cell proliferation and oligodendrocyte survival.
• Molecular analyses revealed lithium modulated neuroinflammatory (reduced IL-1β) and neurotrophic pathways (increased GSK-3β phosphorylation, BDNF, Cyclin D1).

Conclusions:

• Lithium demonstrates significant neuroprotective effects in a neonatal rat model of GMH.
• The therapeutic benefits are likely mediated by the modulation of neuroinflammation, promotion of neurogenesis, and regulation of key molecular pathways.
• These findings highlight lithium's translational potential for improving outcomes in preterm infants affected by GMH.